Integra Lifesciences (IART, Financial), a New Jersey-based medical device company, recently experienced a significant stock price drop of 5.09%, settling at $25.34 per share with a trading volume of 357,430 shares and a turnover rate of 0.46%. The stock's price fluctuation reached 4.48%.
Recent financial reports revealed the company achieved a revenue of $381 million but registered a net loss of $10.7 million, equating to an earnings per share (EPS) of -$0.14. The gross profit stood at $214 million with a price-to-earnings (P/E) ratio of -282.22.
Regarding stock ratings, out of 13 rating agencies, 23% recommend buying, 54% suggest holding, and 23% advise selling the stock. In the broader medical device industry, stocks have decreased by an average of 0.61%.
Within the sector, Outset Medical, Intelligent Bio Solutions, and Myomo, Inc. recorded significant gains. Stocks showing high trading activity included Bluejay Diagnostics, Autonomix Medical, and Tenon Medical. Notable price volatility was observed in Spectral AI Inc C/Wts, Outset Medical, and Bluejay Diagnostics, with fluctuations of 34.74%, 32.90%, and 28.84% respectively.
Integra Lifesciences Holdings Corp focuses on products for regenerative therapies, limb orthopedics, and neurosurgery applications through its two main divisions: the Codman Specialty Surgical and Tissue Technologies divisions, with the former generating the majority of revenue. Integra operates across Europe, the Asia-Pacific region, and other global markets, primarily deriving income from domestic sales.
